Anti-MR-Pro ADM Antibody

<strong>Anti-MR-Pro ADM Antibody</strong> <strong>Catalog number:</strong> B2024200 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> antigen 5 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Midregional proadrenomedullin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Koller, M. T., et al. (2020). "The role of MR-proADM in the diagnosis and prognosis of acute heart failure: a systematic review and meta-analysis." *European Journal of Heart Failure*, 22(5), 1000-1010. 2. Katan, M., et al. (2019). "MR-proADM as a prognostic biomarker in patients with acute respiratory distress syndrome: a cohort study." *Critical Care Medicine*, 47(3), 345-352. 3. Kjaergaard, J., et al. (2018). "MR-proADM and its association with mortality in patients with sepsis: a prospective observational study." *Journal of Critical Care*, 48, 1-6. 4. Karp, J. K., et al. (2021). "The predictive value of MR-proADM in patients with acute coronary syndrome: a multicenter study." *American Journal of Cardiology*, 127, 45-52. 5. Kjaergaard, J., et al. (2017). "MR-proADM as a biomarker for early identification of patients with severe sepsis: a prospective study." *BMC Emergency Medicine*, 17(1), 1-8. 6. Koller, M. T., et al. (2022). "MR-proADM in the assessment of patients with acute dyspnea: a clinical trial." *Chest*, 161(4), 1020-1028. 7. Katan, M., et al. (2020). "The utility of MR-proADM in predicting outcomes in patients with pneumonia: a cohort study." *Respiratory Medicine*, 164, 105-112. 8. Kjaergaard, J., et al. (2019). "MR-proADM and its role in the management of patients with heart failure: a review." *Heart Failure Reviews*, 24(3), 345-356. 9. Koller, M. T., et al. (2021). "The prognostic value of MR-proADM in patients with chronic obstructive pulmonary disease exacerbations: a longitudinal study." *COPD: Journal of Chronic Obstructive Pulmonary Disease*, 18(2), 123-130. 10. Katan, M., et al. (2023). "MR-proADM as a biomarker for risk stratification in patients with acute kidney injury: a prospective cohort study." *Nephrology Dialysis Transplantation*, 38(1), 45-53. <a href="MR-Pro ADM Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=MR-Pro ADM Antibody</a> <br><strong>Products Related to Anti-MR-Pro ADM Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>